Clinical Application of Enteral Microecopharmaceutics Immunonutrition in The Perioperation of Colorectal Cancer_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

 XURui ,  ZHUANGWen

Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, Chengdu 610041, China;

Corresponding author：

ZHUANGWen, Email: ambition123@foxmail.com

Keywords：

Colorectal cancer; Enteral microecopharmaceutics immunonutrition; Clinical application in perioperation

DOI：

10.7507/1007-9424.20140221

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To study the clinical application of enteral microecopharmaceutics immunonutrition in the peroperation of colorectal cancer. Methods Literatures about enteral microecopharmaceutics immunonutrition published in China and abroad were collected and reviewed. Results Early clinical application of enteral microecopharmaceutics immunonutrition in the perioperation can greatly improve the nutritional status of patients with colorectal cancer, increase the patients' immune function, reconstruct the intestinal flora, and reduce the incidence of complications. Conclusions The clinical application of enteral microecopharmaceutics immunonutrition in the perioperation of colorectal cancer can obviously improve patients' nutritional status and immune function, reduce the stress response, and improve its prognosis, but the use of best dose still need further study.

Citation： XURui, ZHUANGWen. Clinical Application of Enteral Microecopharmaceutics Immunonutrition in The Perioperation of Colorectal Cancer. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2014, 21(7): 921-924. doi: 10.7507/1007-9424.20140221 Copy

1.	于康, 周晓容, 郭亚芳.恶性肿瘤住院患者营养风险和营养不足发生率及营养支持应用状况调查[J].肿瘤学杂志, 2011, 17(6) :408-411.
2.	Schwegler I, von Holzen A, Gutzwiller JP, et al. Nutritional risk is a clinical predictor of postoperative mortality and morbidity in surgery for colorectal cancer[J]. Br J Surg, 2010, 97(1):92-97.
3.	Sobhani I, Tap J, Roudot-Thoraval F, et al. Microbial dysbiosis in colorectal cancer (CRC) patients[J]. PLoS One, 2011, 6(1): e16393.
4.	Bengmark S. Ecoimmunonutrition:a challenge for the third millennium[J]. Nutrition, 1998, 14(7-8):563-572.
5.	吴国豪.营养支持在肿瘤治疗中的作用[J].中华普通外科杂志, 2007, 22(9):720-723.
6.	杨锡强.微生态制剂的免疫作用机制[C].第六届全国儿科微生态学学术会议, 深圳, 2008:6-7.
7.	Górska S, Jarzab A, Gamian A. Probiotic bacteria in the human gastrointestinal tract as a factor stimulating the immune system[J]. Postepy Hig Med Dosw, 2009, 63:653-667.
8.	Liu Z, Qin H, Yang Z, et al. Randomised clinical trial:the effects of perioperative probiotic treatment on barrier function and postoperative infectious complications in colorectal cancer surgery-a double-blind study[J]. Aliment Pharmacol Ther, 2011, 33(1):50-63.
9.	Singh VP, Sharma J, Babu S, et al. Role of probiotics in health and disease:a review[J]. J Pak Med Assoc, 2013, 63(2):253-257.
10.	Gupta V, Garg R. Probiotics[J]. Indian J Med Microbiol, 2009, 27(3):202-209.
11.	于江涛, 陈利生.肠内微生态营养支持与结直肠癌的治疗[J].结直肠肛门外科, 2008, 14(3):216-219.
12.	Mario Uccello, Giulia Malaguarnera, Francesco Basile, et al. Potential role of probiotics on colorectal cancer prevention[J]. BMC Surgery, 2012, 12(Suppl 1):S35.
13.	牛辉, 包维民, 龚昆梅, 等.大肠癌患者与正常人肠道菌群的比较研究[J].昆明医学院学报, 2009, 30(12):97-100.
14.	钱昆.肠道微生态制剂在结直肠术后患者中的应用研究[D].四川大学, 2004.
15.	Zhang JW, Du P, Gao J, et al. Preoperative probiotics decrease postoperative infectious complications of colorectal cancer[J]. Am J Med Sci, 2012, 343(3):199-205.
16.	徐兰娟, 曹丽萍.结直肠癌患者的围手术期营养风险筛查与术后并发症[J].中国临床营养杂志, 2009, 17(1):21-23.
17.	陈佳捷, 倪玲, 包斌, 等.肠内营养的研究进展及临床应用[J].食品工业科技, 2013, 34(2):382-386, 391.
18.	赵自然, 康维明, 于健春.消化道肿瘤患者营养支持治疗[J].临床药物治疗杂志, 2013, 11(4):9-13.
19.	Braga M, Gianotti L, Gentilini O, et al. Early postoperative enteral nutrition improves gut oxygenation and reduce costs compared with total parenteral nutrition[J]. Crit Care Med, 2001, 29(2): 242-248.
20.	伍颖君.不同术前肠道准备对结直肠癌术后肠道菌群变化的影响[D].南方医科大学, 2012.
21.	Hungin AP, Mulligan C, Pot B, et al. Systematic review:probiotics in the management of lower gastrointestinal symptoms in clinical practice-an evidencebased international guide[J]. Aliment Pharmacol Ther, 2013, 38(8):864-886.
22.	黎介寿.胃肠手术的"围手术期营养处理"[J].肠外与肠内营养, 2013, 20(2):65-67.
23.	朱达坚, 陈小伍, 伍锦浩, 等.结直肠癌围手术期替代应用肠道微生态制剂对肠道菌群及机体免疫功能的影响[J].南方医科大学学报, 2012, 32(8):1190-1193.
24.	钟静.结直肠癌病人围手术期的营养评估和临床营养支持[J].肠外与肠内营养, 2012, 19(4):246-249.
25.	季兰芳, 罗巧莲.肿瘤患者围手术期肠内免疫营养研究进展[J].护士进修杂志, 2009, 24(1):34-37.
26.	Sakurai Y, Kanaya S, Komori Y, et al. Is postoperative early enteral nutrition with regular or disease-specific enteral formula really beneficial in patients undergoing esophagectomy[J]. Esophagus, 2009, 6(3):149-154.
27.	Stephen A, McClave, Robert G, et al. Guidelines for the provision and assessment of nutritionsupport therapyintheadult critically ill patient; societyof critical caremedicine (SCCM) and American Society for Parenteral and Enteral Nutrition (ASPEN)[C]. JPEN, 2009, 33:277.
28.	朱翠凤, 刘晓平, 白植军, 等.生态免疫营养对消化道恶性肿瘤患者术后营养状况、炎症反应和预后的影响[J].中国临床营养杂志, 2007, 15(2):90-94.
29.	Warren S. The intermediate cause of death in cancer[J]. Am J Med Sci, 1932, 184(3):610-615.
30.	李月春, 王东霞, 胡夏荣, 等.结直肠癌术后早期肠内营养的应用体会[J].中国普外基础与临床杂志, 2008, 15(8):609-611.
31.	邵峰, 张彦波, 杨道贵.免疫微生态营养对结直肠癌病人术后应激和免疫状态的影响[J].肠外与肠内营养, 2011, 18(4): 215-217.
32.	刘连仲.早期肠内营养支持对消化道肿瘤患者术后营养状况及免疫功能的影响[J].中国肿瘤临床与康复, 2013, 20(3): 272-274.
33.	张纪伟, 杜鹏, 陈大伟, 等.补充双歧三联活菌对结直肠癌术后患者免疫状况和炎性反应的影响[J].中华胃肠外科杂志, 2010, 13(1):40-43.
34.	朱达坚, 陈小伍, 伍锦浩, 等.结直肠癌围手术期替代应用肠道微生态制剂对术后炎症反应及感染性并发症的影响[J].广东医学, 2012, 33(14):2121-2123.
35.	杨振, 秦环龙.微生态制剂对大肠癌患者术后炎症反应和肠道屏障功能的影响[A].中华医学会外科学分会临床营养支持学组.中华医学会第十一届全国营养支持学术会议论文汇编[C].中华医学会外科学分会临床营养支持学组, 2008:7.

1. 于康, 周晓容, 郭亚芳.恶性肿瘤住院患者营养风险和营养不足发生率及营养支持应用状况调查[J].肿瘤学杂志, 2011, 17(6) :408-411.
2. Schwegler I, von Holzen A, Gutzwiller JP, et al. Nutritional risk is a clinical predictor of postoperative mortality and morbidity in surgery for colorectal cancer[J]. Br J Surg, 2010, 97(1):92-97.
3. Sobhani I, Tap J, Roudot-Thoraval F, et al. Microbial dysbiosis in colorectal cancer (CRC) patients[J]. PLoS One, 2011, 6(1): e16393.
4. Bengmark S. Ecoimmunonutrition:a challenge for the third millennium[J]. Nutrition, 1998, 14(7-8):563-572.
5. 吴国豪.营养支持在肿瘤治疗中的作用[J].中华普通外科杂志, 2007, 22(9):720-723.
6. 杨锡强.微生态制剂的免疫作用机制[C].第六届全国儿科微生态学学术会议, 深圳, 2008:6-7.
7. Górska S, Jarzab A, Gamian A. Probiotic bacteria in the human gastrointestinal tract as a factor stimulating the immune system[J]. Postepy Hig Med Dosw, 2009, 63:653-667.
8. Liu Z, Qin H, Yang Z, et al. Randomised clinical trial:the effects of perioperative probiotic treatment on barrier function and postoperative infectious complications in colorectal cancer surgery-a double-blind study[J]. Aliment Pharmacol Ther, 2011, 33(1):50-63.
9. Singh VP, Sharma J, Babu S, et al. Role of probiotics in health and disease:a review[J]. J Pak Med Assoc, 2013, 63(2):253-257.
10. Gupta V, Garg R. Probiotics[J]. Indian J Med Microbiol, 2009, 27(3):202-209.
11. 于江涛, 陈利生.肠内微生态营养支持与结直肠癌的治疗[J].结直肠肛门外科, 2008, 14(3):216-219.
12. Mario Uccello, Giulia Malaguarnera, Francesco Basile, et al. Potential role of probiotics on colorectal cancer prevention[J]. BMC Surgery, 2012, 12(Suppl 1):S35.
13. 牛辉, 包维民, 龚昆梅, 等.大肠癌患者与正常人肠道菌群的比较研究[J].昆明医学院学报, 2009, 30(12):97-100.
14. 钱昆.肠道微生态制剂在结直肠术后患者中的应用研究[D].四川大学, 2004.
15. Zhang JW, Du P, Gao J, et al. Preoperative probiotics decrease postoperative infectious complications of colorectal cancer[J]. Am J Med Sci, 2012, 343(3):199-205.
16. 徐兰娟, 曹丽萍.结直肠癌患者的围手术期营养风险筛查与术后并发症[J].中国临床营养杂志, 2009, 17(1):21-23.
17. 陈佳捷, 倪玲, 包斌, 等.肠内营养的研究进展及临床应用[J].食品工业科技, 2013, 34(2):382-386, 391.
18. 赵自然, 康维明, 于健春.消化道肿瘤患者营养支持治疗[J].临床药物治疗杂志, 2013, 11(4):9-13.
19. Braga M, Gianotti L, Gentilini O, et al. Early postoperative enteral nutrition improves gut oxygenation and reduce costs compared with total parenteral nutrition[J]. Crit Care Med, 2001, 29(2): 242-248.
20. 伍颖君.不同术前肠道准备对结直肠癌术后肠道菌群变化的影响[D].南方医科大学, 2012.
21. Hungin AP, Mulligan C, Pot B, et al. Systematic review:probiotics in the management of lower gastrointestinal symptoms in clinical practice-an evidencebased international guide[J]. Aliment Pharmacol Ther, 2013, 38(8):864-886.
22. 黎介寿.胃肠手术的"围手术期营养处理"[J].肠外与肠内营养, 2013, 20(2):65-67.
23. 朱达坚, 陈小伍, 伍锦浩, 等.结直肠癌围手术期替代应用肠道微生态制剂对肠道菌群及机体免疫功能的影响[J].南方医科大学学报, 2012, 32(8):1190-1193.
24. 钟静.结直肠癌病人围手术期的营养评估和临床营养支持[J].肠外与肠内营养, 2012, 19(4):246-249.
25. 季兰芳, 罗巧莲.肿瘤患者围手术期肠内免疫营养研究进展[J].护士进修杂志, 2009, 24(1):34-37.
26. Sakurai Y, Kanaya S, Komori Y, et al. Is postoperative early enteral nutrition with regular or disease-specific enteral formula really beneficial in patients undergoing esophagectomy[J]. Esophagus, 2009, 6(3):149-154.
27. Stephen A, McClave, Robert G, et al. Guidelines for the provision and assessment of nutritionsupport therapyintheadult critically ill patient; societyof critical caremedicine (SCCM) and American Society for Parenteral and Enteral Nutrition (ASPEN)[C]. JPEN, 2009, 33:277.
28. 朱翠凤, 刘晓平, 白植军, 等.生态免疫营养对消化道恶性肿瘤患者术后营养状况、炎症反应和预后的影响[J].中国临床营养杂志, 2007, 15(2):90-94.
29. Warren S. The intermediate cause of death in cancer[J]. Am J Med Sci, 1932, 184(3):610-615.
30. 李月春, 王东霞, 胡夏荣, 等.结直肠癌术后早期肠内营养的应用体会[J].中国普外基础与临床杂志, 2008, 15(8):609-611.
31. 邵峰, 张彦波, 杨道贵.免疫微生态营养对结直肠癌病人术后应激和免疫状态的影响[J].肠外与肠内营养, 2011, 18(4): 215-217.
32. 刘连仲.早期肠内营养支持对消化道肿瘤患者术后营养状况及免疫功能的影响[J].中国肿瘤临床与康复, 2013, 20(3): 272-274.
33. 张纪伟, 杜鹏, 陈大伟, 等.补充双歧三联活菌对结直肠癌术后患者免疫状况和炎性反应的影响[J].中华胃肠外科杂志, 2010, 13(1):40-43.
34. 朱达坚, 陈小伍, 伍锦浩, 等.结直肠癌围手术期替代应用肠道微生态制剂对术后炎症反应及感染性并发症的影响[J].广东医学, 2012, 33(14):2121-2123.
35. 杨振, 秦环龙.微生态制剂对大肠癌患者术后炎症反应和肠道屏障功能的影响[A].中华医学会外科学分会临床营养支持学组.中华医学会第十一届全国营养支持学术会议论文汇编[C].中华医学会外科学分会临床营养支持学组, 2008:7.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Clinical Application of Enteral Microecopharmaceutics Immunonutrition in The Perioperation of Colorectal Cancer

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content